Cargando…

Strategy-making Process and Firm Performance in Iranian Pharmaceutical Industry

This study investigated the relationship between main dimensions in the strategy-making process, environmental complexity, and performance in pharmaceutical companies of Iran. Results argue that pharmaceutical companies like other industries place differing emphasis on strategy-making and employ dif...

Descripción completa

Detalles Bibliográficos
Autores principales: Abolfazli, Seyyed Abolfazl, Mohammadzadeh, Mehdi, Peiravian, Farzad, Zonoozi, Jafar, Sharifnia, Hesam, Vasheghani, Ali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Shaheed Beheshti University of Medical Sciences 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6487417/
https://www.ncbi.nlm.nih.gov/pubmed/31089387
_version_ 1783414497976778752
author Abolfazli, Seyyed Abolfazl
Mohammadzadeh, Mehdi
Peiravian, Farzad
Zonoozi, Jafar
Sharifnia, Hesam
Vasheghani, Ali
author_facet Abolfazli, Seyyed Abolfazl
Mohammadzadeh, Mehdi
Peiravian, Farzad
Zonoozi, Jafar
Sharifnia, Hesam
Vasheghani, Ali
author_sort Abolfazli, Seyyed Abolfazl
collection PubMed
description This study investigated the relationship between main dimensions in the strategy-making process, environmental complexity, and performance in pharmaceutical companies of Iran. Results argue that pharmaceutical companies like other industries place differing emphasis on strategy-making and employ different modes of strategy-making. It offers a typology of different modes of strategy-making that most likely exist in pharmaceutical companies and hypothesizes how this typology relates to performance. It then describes the results of an empirical study of the strategy-making processes of pharmaceutical companies. The structural equation analysis of the data from 31 pharmaceutical companies indicates that there are simplistic, adaptive, entrepreneurial, participative, and SPACE (Strategy making Process According to Complexity Environment) modes of strategy-making in pharmaceutical companies; of these modes, SPACE mode exhibited a significant relationship with performance.
format Online
Article
Text
id pubmed-6487417
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Shaheed Beheshti University of Medical Sciences
record_format MEDLINE/PubMed
spelling pubmed-64874172019-05-14 Strategy-making Process and Firm Performance in Iranian Pharmaceutical Industry Abolfazli, Seyyed Abolfazl Mohammadzadeh, Mehdi Peiravian, Farzad Zonoozi, Jafar Sharifnia, Hesam Vasheghani, Ali Iran J Pharm Res Original Article This study investigated the relationship between main dimensions in the strategy-making process, environmental complexity, and performance in pharmaceutical companies of Iran. Results argue that pharmaceutical companies like other industries place differing emphasis on strategy-making and employ different modes of strategy-making. It offers a typology of different modes of strategy-making that most likely exist in pharmaceutical companies and hypothesizes how this typology relates to performance. It then describes the results of an empirical study of the strategy-making processes of pharmaceutical companies. The structural equation analysis of the data from 31 pharmaceutical companies indicates that there are simplistic, adaptive, entrepreneurial, participative, and SPACE (Strategy making Process According to Complexity Environment) modes of strategy-making in pharmaceutical companies; of these modes, SPACE mode exhibited a significant relationship with performance. Shaheed Beheshti University of Medical Sciences 2019 /pmc/articles/PMC6487417/ /pubmed/31089387 Text en This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (http://creativecommons.org/licenses/by/3.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Abolfazli, Seyyed Abolfazl
Mohammadzadeh, Mehdi
Peiravian, Farzad
Zonoozi, Jafar
Sharifnia, Hesam
Vasheghani, Ali
Strategy-making Process and Firm Performance in Iranian Pharmaceutical Industry
title Strategy-making Process and Firm Performance in Iranian Pharmaceutical Industry
title_full Strategy-making Process and Firm Performance in Iranian Pharmaceutical Industry
title_fullStr Strategy-making Process and Firm Performance in Iranian Pharmaceutical Industry
title_full_unstemmed Strategy-making Process and Firm Performance in Iranian Pharmaceutical Industry
title_short Strategy-making Process and Firm Performance in Iranian Pharmaceutical Industry
title_sort strategy-making process and firm performance in iranian pharmaceutical industry
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6487417/
https://www.ncbi.nlm.nih.gov/pubmed/31089387
work_keys_str_mv AT abolfazliseyyedabolfazl strategymakingprocessandfirmperformanceiniranianpharmaceuticalindustry
AT mohammadzadehmehdi strategymakingprocessandfirmperformanceiniranianpharmaceuticalindustry
AT peiravianfarzad strategymakingprocessandfirmperformanceiniranianpharmaceuticalindustry
AT zonoozijafar strategymakingprocessandfirmperformanceiniranianpharmaceuticalindustry
AT sharifniahesam strategymakingprocessandfirmperformanceiniranianpharmaceuticalindustry
AT vasheghaniali strategymakingprocessandfirmperformanceiniranianpharmaceuticalindustry